Patents Examined by Donato E. Adams
  • Patent number: 5320956
    Abstract: The invention provides novel monoclonal antibodies and the hybridomas that secrete them. The antibodies can be used for the diagnosis of a number of cancers, such as ovarian, esophageal and cervical carcinomas. A preferred antibody is secreted by a hybridoma deposited with the ATCC and has Accession No. HB 10570.
    Type: Grant
    Filed: November 16, 1992
    Date of Patent: June 14, 1994
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mark C. Willingham, Kai Chang, Ira Pastan